Announcement |
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
This is the second year of competition for ATVB New Investigator Awards. The Awards recognize papers published in ATVB in 2006 that were submitted by new investigators and judged to be the most outstanding in the Atherosclerosis/Lipoprotein, Thrombosis, and Vascular Biology sections of the journal. The three awards are named for Dr Daniel Steinberg, who devised a method to determine the site of degradation of the proteins and lipids of a lipoprotein, which led to the concept of selective uptake of cholesterol and apoprotein that characterizes the reverse cholesterol transport pathway; Dr Karl Link, who identified dicoumarol as the hemorrhagic factor in spoiled sweet clover hay, and then developed dicoumarol and warfarin as anticoagulant drugs; and Dr Werner Risau, who formulated key concepts for the regulation of angiogenesis, challenged the prevailing dogmas about angiogenic factors, and proposed the now accepted hypothesis that several growth factors act sequentially to mediate vasculogenesis, angiogenesis, and vascular remodeling.
In the second year of the award, 744 papers were submitted for the Awards. Recipients of the awards are:
Dominick Angiolillo, MD, University of Florida–Shands Jacksonville, the 2007 Karl Link New Investigator Award in Thrombosis, for his paper "Contribution of Gene Sequence Variations of the Hepatic Cytochrome P450 3A4 Enzyme to Variability in Individual Responsiveness to Clopidogrel" (Arterioscler Thromb Vasc Biol. 2006;26:1895–1900).
| |||||||||||
Jacob Bentzon, MD, Aarhus University Hospital (Skejby), the 2007 recipient of the Daniel Steinberg New Investigator Award in Atherosclerosis/Lipoproteins, for his paper "Smooth Muscle Cells in Arteriosclerosis Originate From
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |